Hwang back on the job, cloning dogs
Disgraced Korean stem cell scientist is making a professional comeback as a dog cloner
Disgraced Korean stem cell scientist is making a professional comeback as a dog cloner. Now working at the Sooam Biotech Research Foundation, he and his team cloned 17 Tibetan mastiffs, a rare breed, to fill an order from the Chinese Academy of Sciences. The pups were born in April. No details were given of the success rate of the cloning (how many eggs were required to bring about a live birth). All 17 dogs were cloned from two dogs and six surrogate mothers were used. The foundation says that DNA tests by a separate institute have confirmed that all the dogs are true clones. ~ New York Times, June 20
Michael Cook edits BioEdge, a bioethics newsletter, and MercatorNet, an on-line magazine whose focus is human dignity. He writes from Sydney, Australia.
Latest posts by Michael Cook (see all)
- How long can you put off seeing the doctor because of lockdowns? - December 3, 2021
- House of Lords debates assisted suicide—again - October 28, 2021
- Spanish government tries to restrict conscientious objection - October 28, 2021
More Stories
Mortality rates for American kids are rising for the first time in 50 years
US President Joe Biden is so concerned about the future of American children that he inserted a mandate for affordable...
Will Pope Francis be composted?
Will Pope Francis be composted instead of buried in St Peter’s Basilica in Rome with his predecessors? It’s unlikely. But...
The virtues and the vices of the outrageous
A Norwegian bioethicist, Anna Smajdor, recently set out a case for “Whole Body Gestational Donation” – using the wombs of...
More than 200 people have been treated with experimental CRISPR therapies
Scientists believe that CRISPR gene editing technologies will transform medicine. But how many people have been treated so far? According...
Asia-Pacific IVF market could reach US$46 billion by 2031
According to a market survey by Allied Market Research, IVF is booming in the Asia-Pacific region. The market size was...
Third global summit on human genome editing: Moving on after the He experiment
The much anticipated Third International Summit on Human Genome Editing was held in London earlier this month to explore the...
